You are here

International Consortium Selects ICON to Help Advance Value-Based Health Care

Company launches global health care outcomes benchmarking program

The International Consortium for Health Outcomes Measurement (ICHOM) has selected ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries, to advance value-based health care through the launch of a global health care outcomes benchmarking program called GLOBE.

ICON is using its data management, data analytics, and consultancy expertise to enable ICHOM to provide health care providers with a secure platform to share and compare high-quality, risk-adjusted health outcomes.

ICHOM is an independent, nonprofit organization founded in 2012 with the mission of unlocking the potential of value-based health care by facilitating the measurement and comparison of health outcomes. As a first step in realizing its mission, ICHOM has worked with more than 400 leading clinicians, registry leaders, and patients worldwide to develop standard sets that provide a common language and approach to measuring outcomes at the condition level. The standard sets address 13 conditions that cover approximately 35% of the global disease burden.

To date, more than 70 health care provider systems and academic medical centers worldwide are implementing the ICHOM standard sets to measure health outcomes. The GLOBE initiative will enable providers to compare their patients’ outcomes with those of their peers and to identify opportunities to improve outcomes and/or lower costs while maintaining outcomes.

ICON is drawing on its 25 years of clinical and technical expertise in data management, data analytics, and patient-reported outcomes to help ICHOM deliver a secure platform for health care providers to share and compare their health outcomes collected in accordance with the ICHOM standard sets. ICON is using the capabilities of ICONIK for data standardization, visualization, analytics, and reporting. In addition, ICON is providing scientific, regulatory, and legal consultancy to ICHOM to enable the organization to partner easily with health care providers to create a global provider excellence network.

ICONIK is ICON’s integrated information platform that consolidates, standardizes, and visualizes operational, clinical, and real-world data from multiple sources to provide a single holistic view of all study information. ICONIK can analyze a blend of operational, quality, efficacy, and clinical safety data across multiple studies and different therapeutic areas, making it one of the most effective tools in the industry for the proactive management of a clinical trial.

“Bringing consistency and transparency to the measurement and reporting of health outcomes has the potential to effect real change within the global health care industry,” said Dr. Steve Cutler, Chief Operating Officer of ICON plc. Added Christina Akerman, ICHOM President: “This project will allow any clinics or hospitals that measure our standard sets to understand how they’re doing relative to one another and facilitates the formation of improvement communities where providers can jointly learn and improve.”

Source: ICON plc; March 8, 2016.

Recent Headlines

Disrupting Gut Microbiome Could Be Key
Drug Boosts Levels of Natural Endocannabinoids
Judicious Use of Antibiotics May Not Be Enough To Defeat Bacteria That Carry On By Going Into a Dormant State
KRAS Oncogene Is a Problematic Target So Researchers Are Trying Workdarounds
Understanding Neural Ensembles in Infralimbic Cortex May Lead To Improved Addiction Treatment
Vitamin E Found in Samples Around the Country
Study Links Them to Premature Death
Nag With Texting and a ‘Winners Circle’
How Serotonin and Fluoxetine Affect Microbiota Residing in the Gut